We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02052128
Recruitment Status : Unknown
Verified June 2015 by Arno Therapeutics.
Recruitment status was:  Recruiting
First Posted : January 31, 2014
Last Update Posted : June 24, 2015
Sponsor:
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2015
  Estimated Study Completion Date : April 2016